14.79
0.40%
-0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACAD Giù?
Forum
Previsione
Acadia Pharmaceuticals Inc Azioni (ACAD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
9.14%
231.04
|
211.70 | 165.24 | 118.46 | 136.49 |
Cost Of Revenue |
22.35%
17.89
|
14.62 | 7.459 | 1.667 | 2.414 |
Gross Profit |
8.16%
213.15
|
197.08 | 157.78 | 116.80 | 134.08 |
Operating Expenses
|
30.07%
178.21
|
254.85 | 154.74 | 170.38 | 180.14 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
100.00%
-
|
269.48 | 162.20 | 172.05 | - |
Operating Income/Loss |
160.48%
34.94
|
-57.78 | 3.037 | -53.58 | -46.06 |
Income/Loss From Continuing Operations Before Tax |
543.09%
231.04
|
-52.14 | 6.343 | -44.94 | 136.49 |
Income Tax Expense/Benefit |
146.76%
-6.094
|
13.03 | 5.229 | -1.918 | 0.835 |
Income/Loss From Continuing Operations After Tax |
170.27%
45.80
|
-65.18 | 1.114 | -43.02 | -41.73 |
Net Income/Loss
|
170.27%
45.80
|
-65.18 | 1.114 | -43.02 | -41.73 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.80%
0.000331
|
0.1642 | 0.1635 | 162.26 | 0.000103 |
Diluted Average Shares |
99.80%
0.000331
|
0.1642 | 0.165 | 162.26 | 0.000103 |
Basic Earnings Per Share |
170.00%
0.28
|
-0.40 | 0.01 | -0.27 | -0.26 |
Diluted Earnings Per Share |
170.00%
0.28
|
-0.40 | 0.01 | -0.27 | -0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):